Resected Colorectal Cancer Among Medicare Beneficiaries:Adoption of FDG PET

Radiology - United States
doi 10.1148/radiol.2541090484
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Radiological Society of North America (RSNA)

Related search

Utilization of Bevacizumab Among Medicare Patients With Colorectal Cancer Receiving Chemotherapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

A New Strategy Based on FDG-PET for Managing Liver Metastasis From Colorectal Cancer

HPB
HepatologyGastroenterology
2018English

Suture Granuloma With False-Positive Findings on FDG-PET/CT Resected via Laparoscopic Surgery

International Surgery
Surgery
2015English

18f-FDG PET in Detecting Primary Breast Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2007English

Dual-Time-Point 18f-FDG PET/CT in Patients With Colorectal Cancer: Clinical Value of Early Delayed Scanning

Annals of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

FDG-PET Cancer Screening: Is It Useful for Lung Cancer?

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2005English

Surgery for Colorectal Cancer: Race-Related Differences in Rates and Survival Among Medicare Beneficiaries.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1996English

Trends in Surveillance for Resected Colorectal Cancer, 2001-2009

Cancer
Cancer ResearchOncology
2015English

FDG-PET-based Prognostic Nomograms for Locally Advanced Cervical Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy